Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018.

Brolund A, Lagerqvist N, Byfors S, Struelens MJ, Monnet DL, Albiger B, Kohlenberg A; European Antimicrobial Resistance Genes Surveillance Network EURGen-Net Capacity Survey Group.

Euro Surveill. 2019 Feb;24(9). doi: 10.2807/1560-7917.ES.2019.24.9.1900123.

2.

Investing in Public Health Microbiology Laboratories in Western Balkan Countries Enhances Health Security From Communicable Disease Threats in Europe.

Bajoriniene A, Leitmeyer KC, Struelens MJ, Kokki MH; Observers and Alternate Observers to the ECDC National Microbiology Focal Points in Western Balkan Countries.

Front Public Health. 2019 Feb 4;7:8. doi: 10.3389/fpubh.2019.00008. eCollection 2019.

3.

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.

Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, Ouakrim DA, Oliveira TC, Struelens MJ, Suetens C, Monnet DL; Burden of AMR Collaborative Group.

Lancet Infect Dis. 2019 Jan;19(1):56-66. doi: 10.1016/S1473-3099(18)30605-4. Epub 2018 Nov 5.

4.

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017.

Kohlenberg A, Struelens MJ, Monnet DL, Plachouras D; The Candida Auris Survey Collaborative Group.

Euro Surveill. 2018 Mar;23(13). doi: 10.2807/1560-7917.ES.2018.23.13.18-00136.

5.

Networking of Public Health Microbiology Laboratories Bolsters Europe's Defenses against Infectious Diseases.

Albiger B, Revez J, Leitmeyer KC, Struelens MJ.

Front Public Health. 2018 Feb 26;6:46. doi: 10.3389/fpubh.2018.00046. eCollection 2018.

6.

Control of Infectious Diseases in the Era of European Clinical Microbiology Laboratory Consolidation: New Challenges and Opportunities for the Patient and for Public Health Surveillance.

Vandenberg O, Kozlakidis Z, Schrenzel J, Struelens MJ, Breuer J.

Front Med (Lausanne). 2018 Feb 2;5:15. doi: 10.3389/fmed.2018.00015. eCollection 2018.

7.

Survey on the Use of Whole-Genome Sequencing for Infectious Diseases Surveillance: Rapid Expansion of European National Capacities, 2015-2016.

Revez J, Espinosa L, Albiger B, Leitmeyer KC, Struelens MJ; ECDC National Microbiology Focal Points and Experts Group.

Front Public Health. 2017 Dec 18;5:347. doi: 10.3389/fpubh.2017.00347. eCollection 2017.

8.

Livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) among human MRSA isolates, European Union/European Economic Area countries, 2013.

Kinross P, Petersen A, Skov R, Van Hauwermeiren E, Pantosti A, Laurent F, Voss A, Kluytmans J, Struelens MJ, Heuer O, Monnet DL; The European Human LA-Mrsa Study Group.

Euro Surveill. 2017 Nov;22(44). doi: 10.2807/1560-7917.ES.2017.22.44.16-00696.

9.

Mycobacterium chimaera infections associated with heater-cooler units (HCU): closing another loophole in patient safety.

Struelens MJ, Plachouras D.

Euro Surveill. 2016 Nov 17;21(46). pii: 30397. doi: 10.2807/1560-7917.ES.2016.21.46.30397. No abstract available. Erratum in: Euro Surveill. 2016 Nov 24;21(47):.

10.

Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.

Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL; European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group.

Euro Surveill. 2015;20(45). doi: 10.2807/1560-7917.ES.2015.20.45.30062. Erratum in: Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30089. Euro Surveill. 2016 Sep 22;21(38):.

11.

Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.

Brown D, Canton R, Dubreuil L, Gatermann S, Giske C, MacGowan A, Martinez-Martinez L, Mouton J, Skov R, Steinbakk M, Walton C, Heuer O, Struelens MJ, Diaz Hogberg L, Kahlmeter G.

Euro Surveill. 2015 Jan 15;20(2). pii: 21008.

12.

Laboratory capability and surveillance testing for Middle East respiratory syndrome coronavirus infection in the WHO European Region, June 2013.

Pereyaslov D, Rosin P, Palm D, Zeller H, Gross D, Brown CS, Struelens MJ; MERS-CoV Working Group.

Euro Surveill. 2014 Oct 9;19(40):20923.

13.

Dual-use research debates and public health: better integration would do no harm.

Suk JE, Bartels C, Broberg E, Struelens MJ, Ozin AJ.

Front Public Health. 2014 Sep 12;2:114. doi: 10.3389/fpubh.2014.00114. eCollection 2014. No abstract available.

14.

Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus.

Kock R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Witte W, Friedrich AW.

Euro Surveill. 2014 Jul 24;19(29). pii: 20860. Review.

15.

Impact of rapid molecular screening at hospital admission on nosocomial transmission of methicillin-resistant Staphylococcus aureus: cluster randomised trial.

Roisin S, Laurent C, Denis O, Dramaix M, Nonhoff C, Hallin M, Byl B, Struelens MJ.

PLoS One. 2014 May 16;9(5):e96310. doi: 10.1371/journal.pone.0096310. eCollection 2014.

16.

Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement.

Field N, Cohen T, Struelens MJ, Palm D, Cookson B, Glynn JR, Gallo V, Ramsay M, Sonnenberg P, Maccannell D, Charlett A, Egger M, Green J, Vineis P, Abubakar I.

Lancet Infect Dis. 2014 Apr;14(4):341-52. doi: 10.1016/S1473-3099(13)70324-4. Epub 2014 Mar 14. Review.

PMID:
24631223
17.

Phylogenetic analysis of Staphylococcus aureus CC398 reveals a sub-lineage epidemiologically associated with infections in horses.

Abdelbary MM, Wittenberg A, Cuny C, Layer F, Kurt K, Wieler LH, Walther B, Skov R, Larsen J, Hasman H, Fitzgerald JR, Smith TC, Wagenaar JA, Pantosti A, Hallin M, Struelens MJ, Edwards G, Böse R, Nübel U, Witte W.

PLoS One. 2014 Feb 4;9(2):e88083. doi: 10.1371/journal.pone.0088083. eCollection 2014.

18.

Development and validation of potential structure indicators for evaluating antimicrobial stewardship programmes in European hospitals.

Buyle FM, Metz-Gercek S, Mechtler R, Kern WV, Robays H, Vogelaers D, Struelens MJ; members of the Antibiotic Strategy International (ABS) Quality Indicators Team.

Eur J Clin Microbiol Infect Dis. 2013 Sep;32(9):1161-70. doi: 10.1007/s10096-013-1862-4. Epub 2013 Mar 23.

PMID:
23525773
19.

Subpopulations of Staphylococcus aureus clonal complex 121 are associated with distinct clinical entities.

Kurt K, Rasigade JP, Laurent F, Goering RV, Žemličková H, Machova I, Struelens MJ, Zautner AE, Holtfreter S, Bröker B, Ritchie S, Reaksmey S, Limmathurotsakul D, Peacock SJ, Cuny C, Layer F, Witte W, Nübel U.

PLoS One. 2013;8(3):e58155. doi: 10.1371/journal.pone.0058155. Epub 2013 Mar 7.

20.

Prevalence, risk factors and genetic diversity of methicillin-resistant Staphylococcus aureus carried by humans and animals across livestock production sectors.

Vandendriessche S, Vanderhaeghen W, Soares FV, Hallin M, Catry B, Hermans K, Butaye P, Haesebrouck F, Struelens MJ, Denis O.

J Antimicrob Chemother. 2013 Jul;68(7):1510-6. doi: 10.1093/jac/dkt047. Epub 2013 Feb 20.

PMID:
23429641
21.

From molecular to genomic epidemiology: transforming surveillance and control of infectious diseases.

Struelens MJ, Brisse S.

Euro Surveill. 2013 Jan 24;18(4):20386. No abstract available.

22.

Community-acquired methicillin-resistant Staphylococcus aureus clones circulating in Belgium from 2005 to 2009: changing epidemiology.

Brauner J, Hallin M, Deplano A, De Mendonça R, Nonhoff C, De Ryck R, Roisin S, Struelens MJ, Denis O.

Eur J Clin Microbiol Infect Dis. 2013 May;32(5):613-20. doi: 10.1007/s10096-012-1784-6. Epub 2012 Dec 13.

PMID:
23232976
23.

Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012.

Palm D, Pereyaslov D, Vaz J, Broberg E, Zeller H, Gross D, Brown CS, Struelens MJ; Joint ECDC-WHO Regional Office for Europe Novel Coronavirus Laboratory Survey participants; ECDC National Microbiology Focal Points; WHO European Region EuroFlu Network; European Network for Diagnostics of "Imported" Viral Diseases (ENIVD).

Euro Surveill. 2012 Dec 6;17(49). pii: 20335.

24.

Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics.

Buyle FM, Metz-Gercek S, Mechtler R, Kern WV, Robays H, Vogelaers D, Struelens MJ; Antibiotic Strategy International-ABS Quality Indicators Team.

J Antimicrob Chemother. 2012 Aug;67(8):2043-6. doi: 10.1093/jac/dks145. Epub 2012 May 7.

PMID:
22566589
25.

Previous healthcare exposure is the main antecedent for methicillin-resistant Staphylococcus aureus carriage on hospital admission in Belgium.

Vandendriessche S, Hallin M, Catry B, Jans B, Deplano A, Nonhoff C, Roisin S, De Mendonça R, Struelens MJ, Denis O.

Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2283-92. doi: 10.1007/s10096-012-1567-0. Epub 2012 Mar 1.

PMID:
22382816
26.

Molecular epidemiology of human pathogens: how to translate breakthroughs into public health practice, Stockholm, November 2011.

Palm D, Johansson K, Ozin A, Friedrich A, Grundmann H, Larsson J, Struelens M.

Euro Surveill. 2012 Jan 12;17(2). pii: 20054. No abstract available.

27.

Positive predictive value of the Xpert MRSA assay diagnostic for universal patient screening at hospital admission: influence of the local ecology.

Roisin S, Laurent C, Nonhoff C, Deplano A, Hallin M, Byl B, Struelens MJ, Denis O.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):873-80. doi: 10.1007/s10096-011-1387-7. Epub 2011 Aug 28.

PMID:
21874398
28.

Controlled performance evaluation of the DiversiLab repetitive-sequence-based genotyping system for typing multidrug-resistant health care-associated bacterial pathogens.

Deplano A, Denis O, Rodriguez-Villalobos H, De Ryck R, Struelens MJ, Hallin M.

J Clin Microbiol. 2011 Oct;49(10):3616-20. doi: 10.1128/JCM.00528-11. Epub 2011 Aug 3.

29.

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL.

Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27.

30.
31.

Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe.

Read RC, Cornaglia G, Kahlmeter G; European Society of Clinical Microbiology and Infectious Diseases Professional Affairs Workshop group.

Lancet Infect Dis. 2011 May;11(5):408-15. doi: 10.1016/S1473-3099(10)70294-2. Review.

PMID:
21530895
32.

Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA).

Harbarth S, Hawkey PM, Tenover F, Stefani S, Pantosti A, Struelens MJ.

Int J Antimicrob Agents. 2011 Feb;37(2):110-7. doi: 10.1016/j.ijantimicag.2010.10.022. Epub 2010 Dec 15. Review.

PMID:
21163628
33.

Diversity of accessory genome of human and livestock-associated ST398 methicillin resistant Staphylococcus aureus strains.

Hallin M, De Mendonça R, Denis O, Lefort A, El Garch F, Butaye P, Hermans K, Struelens MJ.

Infect Genet Evol. 2011 Mar;11(2):290-9. doi: 10.1016/j.meegid.2010.10.021. Epub 2010 Dec 9.

PMID:
21145988
34.

New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe.

Struelens MJ, Monnet DL, Magiorakos AP, Santos O'Connor F, Giesecke J; European NDM-1 Survey Participants.

Euro Surveill. 2010 Nov 18;15(46). pii: 19716.

35.

Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe.

Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torné A, Witte W, Friedrich AW.

Euro Surveill. 2010 Oct 14;15(41):19688. Review. Erratum in: Euro Surveill. 2010;15(42). pii: 19694.

36.

Prevention of methicillin‐resistant Staphylococcus aureus infection: is Europe winning the fight?

Struelens MJ, Monnet D.

Infect Control Hosp Epidemiol. 2010 Nov;31 Suppl 1:S42-4. doi: 10.1086/655997.

PMID:
20929368
37.

Evaluation of the Xpert MRSA assay for rapid detection of methicillin-resistant Staphylococcus aureus from nares swabs of geriatric hospitalized patients and failure to detect a specific SCCmec type IV variant.

Laurent C, Bogaerts P, Schoevaerdts D, Denis O, Deplano A, Swine C, Struelens MJ, Glupczynski Y.

Eur J Clin Microbiol Infect Dis. 2010 Aug;29(8):995-1002. doi: 10.1007/s10096-010-0958-3. Epub 2010 May 29.

PMID:
20512518
38.

Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey.

Van Gastel E, Costers M, Peetermans WE, Struelens MJ; Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee.

J Antimicrob Chemother. 2010 Mar;65(3):576-80. doi: 10.1093/jac/dkp470. Epub 2010 Jan 6.

PMID:
20053695
39.

Antibiotic stewardship implementation in the EU: the way forward.

Allerberger F, Gareis R, Jindrák V, Struelens MJ.

Expert Rev Anti Infect Ther. 2009 Dec;7(10):1175-83. doi: 10.1586/eri.09.96.

PMID:
19968511
40.

Detection of microbial DNAemia: does it matter for sepsis management?

Struelens MJ.

Intensive Care Med. 2010 Feb;36(2):193-5. doi: 10.1007/s00134-009-1710-2. Epub 2009 Nov 19. No abstract available.

PMID:
19924397
41.

Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals.

Bogaerts P, Rodriguez-Villalobos H, Bauraing C, Deplano A, Laurent C, Berhin C, Struelens MJ, Glupczynski Y.

Pathol Biol (Paris). 2010 Feb;58(1):78-83. doi: 10.1016/j.patbio.2009.07.035. Epub 2009 Nov 4.

PMID:
19892478
42.

Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium.

Denis O, Jans B, Deplano A, Nonhoff C, De Ryck R, Suetens C, Struelens MJ.

J Antimicrob Chemother. 2009 Dec;64(6):1299-306. doi: 10.1093/jac/dkp345. Epub 2009 Sep 24.

PMID:
19808236
43.

First case of bacteremia caused by Moellerella wisconsensis: case report and a review of the literature.

Cardentey-Reyes A, Jacobs F, Struelens MJ, Rodriguez-Villalobos H.

Infection. 2009 Dec;37(6):544-6. doi: 10.1007/s15010-009-8446-3. Review.

PMID:
19730786
44.

Antibiotic stewardship and consumption: findings from a pan-European hospital study.

Bruce J, MacKenzie FM, Cookson B, Mollison J, van der Meer JW, Krcmery V, Gould IM; ARPAC Steering Group.

J Antimicrob Chemother. 2009 Oct;64(4):853-60. doi: 10.1093/jac/dkp268. Epub 2009 Aug 12.

PMID:
19675012
45.

Methicillin-resistant Staphylococcus aureus ST398 in swine farm personnel, Belgium.

Denis O, Suetens C, Hallin M, Catry B, Ramboer I, Dispas M, Willems G, Gordts B, Butaye P, Struelens MJ.

Emerg Infect Dis. 2009 Jul;15(7):1098-101. doi: 10.3201/eid1507.080652.

46.

spa typing for epidemiological surveillance of Staphylococcus aureus.

Hallin M, Friedrich AW, Struelens MJ.

Methods Mol Biol. 2009;551:189-202. doi: 10.1007/978-1-60327-999-4_15.

PMID:
19521876
47.

Guidelines and indicators for methicillin-resistant Staphylococcus aureus control in hospitals: toward international agreement?

Struelens MJ.

Curr Opin Infect Dis. 2009 Aug;22(4):337-8. doi: 10.1097/QCO.0b013e32832dbae9. No abstract available.

PMID:
19491673
48.

StaphVar-DNA microarray analysis of accessory genome elements of community-acquired methicillin-resistant Staphylococcus aureus.

El Garch F, Hallin M, De Mendonça R, Denis O, Lefort A, Struelens MJ.

J Antimicrob Chemother. 2009 May;63(5):877-85. doi: 10.1093/jac/dkp089. Epub 2009 Mar 19.

PMID:
19299473
49.

Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs.

Struelens MJ, Hawkey PM, French GL, Witte W, Tacconelli E.

Clin Microbiol Infect. 2009 Feb;15(2):112-9. doi: 10.1111/j.1469-0691.2009.02698.x. Review.

50.

Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals.

Bogaerts P, Rodriguez-Villalobos H, Laurent C, Deplano A, Struelens MJ, Glupczynski Y.

J Antimicrob Chemother. 2009 May;63(5):1073-5. doi: 10.1093/jac/dkp046. Epub 2009 Feb 24. No abstract available.

PMID:
19240070

Supplemental Content

Loading ...
Support Center